Takayasu arteritis is a rare, systemic, most commonly affects women of childbearing age. It is a inflammatory large-vessel vasculitis disease involving inflammation in the walls of the largest arteries in the body: the aorta and its main branches. The disease results from an attack by the body's own immune system, causing inflammation in the walls of arteries.
Takayasu’s arteritis female patients (n=30) had a mean age of 33 years and 70% were white race. All patients had body mass index below 30 kg and the mean disease duration was 6 years. More than half (57%) of patients studied were in use of prednisone but low daily doses were observed in TA patients ( mg/d). Systemic arterial hypertension (Blood pressure mmHg, 140 or antihypertensive use) was observed in eighty percent of TA patients
Particularly these patients needing immunosuppressive drugs. Glucocorticoids (prednisone, prednisolone or others), often referred to as “steroids,” are an important part of treatment. The dose and length of treatment depend on how bad the disease is and how long the patient has had it. Lasting damage to arteries sometimes needs a vascular procedure or surgical treatment.